Dexamethasone: US doctors cast doubt on UK’s coronavirus ‘breakthrough’

“We have been burned before, not just during the coronavirus pandemic but even pre-Covid, with exciting results that when we have access to the data are not as convincing,” said Dr Kathryn Hibbert, director of the intensive care unit at Harvard’s Massachusetts General Hospital. Professor Peter Horby of Oxford University said the Recovery Trial project findings show the drug would, on average, prevent one death in every eight Covid-19 patients in intensive care units. “Now that effective treatments for Covid-19 are being confidently discovered through trials on the scale of Recovery, there is realistic scope for further improving the clinical management of this devastating disease.” Additional reporting by Reuters